SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hoffman Robert – ‘4’ for 3/31/02 re: Arena Pharmaceuticals Inc.

As of:  Monday, 4/8/02   ·   For:  3/31/02   ·   Accession #:  912057-2-14067   ·   File #:  0-31161

Previous ‘4’:  None   ·   Next:  ‘4’ on 1/3/03 for 12/31/02   ·   Latest:  ‘4’ on 9/1/23 for 8/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/08/02  Hoffman Robert                    4          Officer     1:71K  Arena Pharmaceuticals Inc.        Toppan Merrill-FA2/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     65K 
                Securities by an Insider

This is an HTML Document rendered as filed.  [ Alternative Formats ]


        FORM 4
o Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

(Print or Type Responses)		   UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF
CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940		  
OMB APPROVAL
OMB Number:        3235-0287
Expires: January 31, 2005
Estimated average burden hours per response .... 0.5
1.   Name and Address of Reporting Person*   2.   Issuer Name and Ticker or Trading Symbol   6.   Relationship of Reporting Person(s) to Issuer (Check all applicable)
    Hoffman   Robert           Arena Pharmaceuticals, Inc. (ARNA)                Director            10% Owner
 
           
    (Last)   (First)   (Middle)   3.   I.R.S. Identification Number of Reporting Person (voluntary)   4.   Statement for Month/Year         X   Officer
  (give title below)		          Other
  (specify below)
    6166 Nancy Ridge Drive               March 2002       Vice President, Finance
 
 
     
(Street)           5.   If Amendment, Date of Original (Month/Year)   7.   Individual or Joint/Group Filing
(Check Applicable Line)
    X     Form filed by One Reporting Person
             Form filed by More than One
    San Diego   California   92121                       Reporting Person
    (City)   (State)   (Zip)                            
                Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.   Title of Security
(Instr. 3)		   2.   Transaction Date   3.   Transaction Code
(Instr. 8)		   4.   Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		   5.   Amount of Securities Beneficially Owned at End of Month   6.   Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		   7.   Nature of Indirect Beneficial Ownership
(Instr. 4)
            (Month/ Day/ Year)  
      (Instr. 3 and 4)                
                    Code   V       Amount   (A) or (D)   Price                        
    Common Stock                                           27,918(1)       D        
                                                                 
                                                                 
                                                                 
                                                               
(1)
Includes 413 shares acquired under the Arena stock purchase plan in March 2002.
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.   (Over)
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).   SEC 1474 (7-97)

POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.

FORM 4 (Continued)   Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1.   Title of Derivative Security
(Instr. 3)		   2.   Conversion or Exercise Price of Derivative Security   3.   Transaction Date
(Month/Day/Year)		   4.   Transaction Code
(Instr. 8)		   5.   Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		   6.   Date Exercisable and Expiration Date (Month/Day/Year)
                       
 
                            Code   V       (A)   (D)       Date
Exercisable		   Expiration Date
Employee Stock Option (right to buy)       $0.60                                       3/3/04   3/3/10
Employee Stock Option (right to buy)       $24.23                                       8/22/01   8/22/10
Employee Stock Option (right to buy)       $24.23                                       8/22/02   8/22/10
Employee Stock Option (right to buy)       $24.23                                       8/22/03   8/22/10
Employee Stock Option (right to buy)       $24.23                                       8/22/04   8/22/10
Employee Stock Option (right to buy)       $25.58                                       7/31/02   7/31/11
Employee Stock Option (right to buy)       $25.58                                       7/31/03   7/31/11
Employee Stock Option (right to buy)       $25.58                                       7/31/04   7/31/11
Employee Stock Option (right to buy)       $25.58                                       7/31/05   7/31/11
Employee Stock Option (right to buy)       $12.25                                       1/15/03   1/15/12
Employee Stock Option (right to buy)       $12.25                                       1/15/04   1/15/12
Employee Stock Option (right to buy)       $12.25                                       1/15/05   1/15/12
Employee Stock Option (right to buy)       $12.25                                       1/15/06   1/15/12
7.   Title and Amount of Underlying Securities
(Instr. 3 and 4)		   8.   Price of Derivative Security
(Instr. 5)		   9.   Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)		   10.   Ownership Form of Derivative Securities Beneficially Owned at End of Month (Instr. 4)   11.   Nature of Indirect Beneficial Ownership
(Instr. 4)
   
                               
    Title   Amount or Number of Shares                                
    Common Stock   5,000               5,000       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        
    Common Stock   2,500               2,500       D        

Explanation of Responses:

    /s/ Robert Hoffman   4/03/02
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).  
**Signature of Reporting Person		  
Date
         
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.       Page 2 of 2
 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘4’ Filing    Date    Other Filings
1/31/05SC 13D
Filed on:4/8/024
For Period end:3/31/0210-Q,  4
 List all Filings 
↑Top
Filing Submission 0000912057-02-014067   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 15, 8:16:36.1pm ET